TARA GULSBY: Open Payments
NPI 1568897767 · LOGANVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 21 payments from 12 companies in 2025. Trend: 2023 $464 · 2024 $325 · 2025 $508
Food & beverage: $409Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $144 |
| PFIZER INC. | 3 | $71 |
| ABBVIE INC. | 3 | $57 |
| Madrigal Pharmaceuticals | 3 | $51 |
| Ipsen Biopharmaceuticals, Inc | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $27 |
| Ardelyx, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: TREMFYA, XELJANZ, SKYRIZI, DUPIXENT, REZDIFFRA, IQIRVO, IBSRELA, OMVOH.
Industry payments across GA — which companies pay providers there.
